CD19 and non-Hodgkin lymphoma: Used by Maschan and Shah et al. for CAR T production for relapsed/refractory B-cell ALL and Non-Hodgkin's lymphoma (11, 32).Used for in-house, POC CD19/20/22 CAR T production (NCT05418088).